Ceritinib-noxalk (150 mg)

NATCO PHARMA LIMITED (INDIA)

“Ceritinib” is the Drug / Molecule content in “Noxalk”. It is an anaplastic lymphoma kinase (ALK) positive inhibitor primarily used for the treatment of metastatic NSCLC. Noxalk thus acts to inhibit mutated enzyme and stop cell proliferation, ultimately halting cancer progression.

Category:

Indication

Ceritinib is used for the treatment of non-small cell lung cancer.

Note

Precaution

  • Ceritinib is a prescription drug and should be used under proper medical guidance and advice.
  • Ceritinib may cause severe, life-threatening or fatal interstitial lung disease / pneumonitis

Related products